Chronic Gastritis Questions & Answers

1. Szabo IL, Cseko K, Czimmer J, Mozsik G. Diagnosis of gastritis – Review from early pathological evaluation to present day management. Mozsik G, ed. Current Topics in Gastritis - 2012. Rijeka, Croatia: In Tech; 2012. Chap 1. [Full Text].

2. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4. 1(8336):1273-5. [QxMD MEDLINE Link].

3. Gao L, Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Alcohol consumption and chronic atrophic gastritis: population-based study among 9,444 older adults from Germany. Int J Cancer. 2009 Dec 15. 125(12):2918-22. [QxMD MEDLINE Link].

4. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996 Oct. 20(10):1161-81. [QxMD MEDLINE Link].

5. Sepulveda AR, Patil M. Practical approach to the pathologic diagnosis of gastritis. Arch Pathol Lab Med. 2008 Oct. 132(10):1586-93. [QxMD MEDLINE Link].

6. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. 1995. 9 Suppl 2:33-9. [QxMD MEDLINE Link].

7. Johnson KS, Ottemann KM. Colonization, localization, and inflammation: the roles of H. pylori chemotaxis in vivo. Curr Opin Microbiol. 2017 Dec 1. 41:51-7. [QxMD MEDLINE Link].

8. Mommersteeg MC, Yu J, Peppelenbosch MP, Fuhler GM. Genetic host factors in Helicobacter pylori-induced carcinogenesis: emerging new paradigms. Biochim Biophys Acta. 2017 Nov 24. 1869(1):42-52. [QxMD MEDLINE Link].

9. Leker K, Lozano-Pope I, Bandyopadhyay K, Choudhury BP, Obonyo M. Comparison of lipopolysaccharides composition of two different strains of Helicobacter pylori. BMC Microbiol. 2017 Dec 4. 17(1):226. [QxMD MEDLINE Link].

10. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010 Apr 29. 362(17):1597-604. [QxMD MEDLINE Link].

11. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA. 1994 Jul 6. 272(1):65-9. [QxMD MEDLINE Link].

12. Shiotani A, Nurgalieva ZZ, Yamaoka Y, Graham DY. Helicobacter pylori. Med Clin North Am. 2000 Sep. 84(5):1125-36, viii. [QxMD MEDLINE Link].

13. Ihan A, Pinchuk IV, Beswick EJ. Inflammation, immunity, and vaccines for Helicobacter pylori infection. Helicobacter. 2012 Sep. 17(Suppl 1):16-21. [QxMD MEDLINE Link]. [Full Text].

14. Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology. 2007 Jul. 133(1):288-308. [QxMD MEDLINE Link].

15. Zalewska-Ziob M, Adamek B, Strzelczyk JK, et al. TNF-alpha expression in gastric mucosa of individuals infected with different virulent Helicobacter pylori strains. Med Sci Monit. 2009 Jun. 15(6):BR166-71. [QxMD MEDLINE Link].

16. Adamsson J, Ottsjo LS, Lundin SB, Svennerholm AM, Raghavan S. Gastric expression of IL-17A and IFNγ in Helicobacter pylori infected individuals is related to symptoms. Cytokine. 2017 Nov. 99:30-4. [QxMD MEDLINE Link].

17. Wallace JL. Gastric ulceration: critical events at the neutrophil--endothelium interface. Can J Physiol Pharmacol. 1993 Jan. 71(1):98-102. [QxMD MEDLINE Link].

18. Graham DY, Opekun A, Lew GM, Evans DJ Jr, Klein PD, Evans DG. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol. 1990 Apr. 85(4):394-8. [QxMD MEDLINE Link].

19. Graham DY, Go MF, Lew GM, Genta RM, Rehfeld JF. Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing. Scand J Gastroenterol. 1993 Aug. 28(8):690-4. [QxMD MEDLINE Link].

20. Salama NR, Hartung ML, Muller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol. 2013 Jun. 11(6):385-99. [QxMD MEDLINE Link]. [Full Text].

21. Gao L, Weck MN, Nieters A, Brenner H. Inverse association between a pro-inflammatory genetic profile and Helicobacter pylori seropositivity among patients with chronic atrophic gastritis: enhanced elimination of the infection during disease progression?. Eur J Cancer. 2009 Nov. 45(16):2860-6. [QxMD MEDLINE Link].

22. Wang SY, Shen XY, Wu CY, et al. Analysis of whole genomic expression profiles of Helicobacter pylori related chronic atrophic gastritis with IL-1B-31CC/-511TT genotypes. J Dig Dis. 2009 May. 10(2):99-106. [QxMD MEDLINE Link].

23. Paniagua GL, Monroy E, Rodriguez R, et al. Frequency of vacA, cagA and babA2 virulence markers in Helicobacter pylori strains isolated from Mexican patients with chronic gastritis. Ann Clin Microbiol Antimicrob. 2009 Apr 30. 8:14. [QxMD MEDLINE Link]. [Full Text].

24. Antonio-Rincon F, Lopez-Vidal Y, Castillo-Rojas G, et al. Pathogenicity island cag, vacA and IS605 genotypes in Mexican strains of Helicobacter pylori associated with peptic ulcers. Ann Clin Microbiol Antimicrob. 2011 May 13. 10:18. [QxMD MEDLINE Link]. [Full Text].

25. Conteduca V, Sansonno D, Lauletta G, Russi S, Ingravallo G, Dammacco F. H pylori infection and gastric cancer: state of the art (review). Int J Oncol. 2013 Jan. 42(1):5-18. [QxMD MEDLINE Link].

26. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001 Sep 13. 345(11):784-9. [QxMD MEDLINE Link].

27. Judaki A, Norozi S, Ahmadi MRH, Ghavam SM, Asadollahi K, Rahmani A. Flow mediated dilation and carotid intima media thickness in patients with chronic gastritis associated with Helicobacter pylori infection. Arq Gastroenterol. 2017 Dec. 54(4):300-4. [QxMD MEDLINE Link].

28. Zhao B, Zhao J, Cheng WF, et al. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol. 2014 Mar. 48(3):241-7. [QxMD MEDLINE Link].

29. Delgado JS, Landa E, Ben-Dor D. Granulomatous gastritis and Helicobacter pylori infection. Isr Med Assoc J. 2013 Jun. 15(6):317-8. [QxMD MEDLINE Link].

30. Ueno M, Shimodate Y, Yamamoto S, Yamamoto H, Mizuno M. Gastric cancer associated with refractory cytomegalovirus gastritis. Clin J Gastroenterol. 2017 Dec. 10(6):498-502. [QxMD MEDLINE Link].

31. Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis--pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013 Sep. 10(9):529-41. [QxMD MEDLINE Link].

32. Hung OY, Maithel SK, Willingham FF, Farris AB 3rd, Kauh JS. Hypergastrinemia, type 1 gastric carcinoid tumors: diagnosis and management. J Clin Oncol. 2011 Sep 1. 29(25):e713-5. [QxMD MEDLINE Link].

33. Gilligan CJ, Lawton GP, Tang LH, West AB, Modlin IM. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol. 1995 Mar. 90(3):338-52. [QxMD MEDLINE Link].

34. Conn DA. Detection of type I and type II antibodies to intrinsic factor. Med Lab Sci. 1986 Apr. 43(2):148-51. [QxMD MEDLINE Link].

35. Ectors NL, Dixon MF, Geboes KJ, Rutgeerts PJ, Desmet VJ, Vantrappen GR. Granulomatous gastritis: a morphological and diagnostic approach. Histopathology. 1993 Jul. 23(1):55-61. [QxMD MEDLINE Link].

36. Wu TT, Hamilton SR. Lymphocytic gastritis: association with etiology and topology. Am J Surg Pathol. 1999 Feb. 23(2):153-8. [QxMD MEDLINE Link].

37. Wolber R, Owen D, DelBuono L, Appelman H, Freeman H. Lymphocytic gastritis in patients with celiac sprue or spruelike intestinal disease. Gastroenterology. 1990 Feb. 98(2):310-5. [QxMD MEDLINE Link].

38. Feeley KM, Heneghan MA, Stevens FM, McCarthy CF. Lymphocytic gastritis and coeliac disease: evidence of a positive association. J Clin Pathol. 1998 Mar. 51(3):207-10. [QxMD MEDLINE Link]. [Full Text].

39. Haot J, Hamichi L, Wallez L, Mainguet P. Lymphocytic gastritis: a newly described entity: a retrospective endoscopic and histological study. Gut. 1988 Sep. 29(9):1258-64. [QxMD MEDLINE Link]. [Full Text].

40. Lambert R, Andre C, Moulinier B, Bugnon B. Diffuse varioliform gastritis. Digestion. 1978. 17(2):159-67. [QxMD MEDLINE Link].

41. Makinen JM, Niemela S, Kerola T, Lehtola J, Karttunen TJ. Epithelial cell proliferation and glandular atrophy in lymphocytic gastritis: effect of H pylori treatment. World J Gastroenterol. 2003 Dec. 9(12):2706-10. [QxMD MEDLINE Link].

42. Ruget O, Burtin P, Cerez H, Cales P, Boyer J. Chronic diarrhea associated with villous atrophy and lymphocytic gastritis, caused by ticlopidine. Gastroenterol Clin Biol. 1992. 16(3):290. [QxMD MEDLINE Link].

43. Sheikh RA, Prindiville TP, Pecha RE, Ruebner BH. Unusual presentations of eosinophilic gastroenteritis: case series and review of literature. World J Gastroenterol. 2009 May 7. 15(17):2156-61. [QxMD MEDLINE Link]. [Full Text].

44. Sell A, Jensen TS. Acute gastric ulcers induced by radiation. Acta Radiol Ther Phys Biol. 1966 Aug. 4(4):289-97. [QxMD MEDLINE Link].

45. Flobert C, Cellier C, Landi B, et al. [Severe hemorrhagic gastritis of radiation origin]. Gastroenterol Clin Biol. 1998 Feb. 22(2):232-4. [QxMD MEDLINE Link].

46. Quentin V, Dib N, Thouveny F, L'Hoste P, Croue A, Boyer J. Chronic ischemic gastritis: case report of a difficult diagnosis and review of the literature. Endoscopy. 2006 May. 38(5):529-32. [QxMD MEDLINE Link].

47. Chambon JP, Bianchini A, Massouille D, Perot C, Lancelevee J, Zerbib P. Ischemic gastritis: a rare but lethal consequence of celiac territory ischemic syndrome. Minerva Chir. 2012 Oct. 67(5):421-8. [QxMD MEDLINE Link].

48. Sipponen P, Maaroos HI. Chronic gastritis. Scand J Gastroenterol. 2015 Jun. 50(6):657-67. [QxMD MEDLINE Link].

49. Singhal AV, Sepulveda AR. Helicobacter heilmannii gastritis: a case study with review of literature. Am J Surg Pathol. 2005 Nov. 29(11):1537-9. [QxMD MEDLINE Link].

50. Hasegawa Y, Goto A, Nishimura S, Sukawa Y, Fujii K, Suzuki K. Cytomegalovirus gastritis after treatment with rituximab. Endoscopy. 2009 Jul. 41(S 02):E199. [QxMD MEDLINE Link].

51. Genta RM. Differential diagnosis of reactive gastropathy. Semin Diagn Pathol. 2005 Nov. 22(4):273-83. [QxMD MEDLINE Link].

52. Shapiro JL, Goldblum JR, Petras RE. A clinicopathologic study of 42 patients with granulomatous gastritis. Is there really an "idiopathic" granulomatous gastritis?. Am J Surg Pathol. 1996 Apr. 20(4):462-70. [QxMD MEDLINE Link].

53. Maeng L, Lee A, Choi K, Kang CS, Kim KM. Granulomatous gastritis: a clinicopathologic analysis of 18 biopsy cases. Am J Surg Pathol. 2004 Jul. 28(7):941-5. [QxMD MEDLINE Link].

54. Leung ST, Chandan VS, Murray JA, Wu TT. Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases. Am J Surg Pathol. 2009 May. 33(5):788-98. [QxMD MEDLINE Link].

55. Gabrieli D, Ciccone F, Capannolo A, et al. Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet. United European Gastroenterol J. 2017 Oct. 5(6):805-10. [QxMD MEDLINE Link].

56. Galiatsatos P, Gologan A, Lamoureux E. Autistic enterocolitis: fact or fiction?. Can J Gastroenterol. 2009 Feb. 23(2):95-8. [QxMD MEDLINE Link]. [Full Text].

57. Rosenberg JJ. Helicobacter pylori. Pediatr Rev. 2010 Feb. 31(2):85-6; discussion 86. [QxMD MEDLINE Link].

58. Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000 Apr. 181(4):1359-63. [QxMD MEDLINE Link].

59. Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am. 2000 Sep. 29(3):559-78. [QxMD MEDLINE Link].

60. Siao D, Somsouk M. Helicobacter pylori: evidence-based review with a focus on immigrant populations. J Gen Intern Med. 2014 Mar. 29(3):520-8. [QxMD MEDLINE Link]. [Full Text].

61. Nabwera HM, Nguyen-Van-Tam JS, Logan RF, Logan RP. Prevalence of Helicobacter pylori infection in Kenyan schoolchildren aged 3-15 years and risk factors for infection. Eur J Gastroenterol Hepatol. 2000 May. 12(5):483-7. [QxMD MEDLINE Link].

62. Sathar MA, Gouws E, Simjee AE, Mayat AM. Seroepidemiological study of Helicobacter pylori infection in South African children. Trans R Soc Trop Med Hyg. 1997 Jul-Aug. 91(4):393-5. [QxMD MEDLINE Link].

63. Zajacova A, Dowd JB, Aiello AE. Socioeconomic and race/ethnic patterns in persistent infection burden among U.S. adults. J Gerontol A Biol Sci Med Sci. 2009 Feb. 64(2):272-9. [QxMD MEDLINE Link]. [Full Text].

64. Dattoli VC, Veiga RV, da Cunha SS, Pontes-de-Carvalho LC, Barreto ML, Alcantara-Neves NM. Seroprevalence and potential risk factors for Helicobacter pylori infection in Brazilian children. Helicobacter. 2010 Aug. 15(4):273-8. [QxMD MEDLINE Link]. [Full Text].

65. Tsai CJ, Perry S, Sanchez L, Parsonnet J. Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area. Am J Epidemiol. 2005 Aug 15. 162(4):351-7. [QxMD MEDLINE Link].

66. Lin DB, Lin JB, Chen CY, Chen SC, Chen WK. Seroprevalence of Helicobacter pylori infection among schoolchildren and teachers in Taiwan. Helicobacter. 2007 Jun. 12(3):258-64. [QxMD MEDLINE Link].

67. Rubio CA, Befritz R, Eriksson B, Christensson B, Duvander A, Larsson B. The topographic distribution of lymphocytic gastritis in gastrectomy specimens. APMIS. 1991 Sep. 99(9):815-9. [QxMD MEDLINE Link].

68. Jaskiewicz K, Price SK, Zak J, Louwrens HD. Lymphocytic gastritis in nonulcer dyspepsia. Dig Dis Sci. 1991 Aug. 36(8):1079-83. [QxMD MEDLINE Link].

69. Tanih NF, Dube C, Green E, et al. An African perspective on Helicobacter pylori: prevalence of human infection, drug resistance, and alternative approaches to treatment. Ann Trop Med Parasitol. 2009 Apr. 103(3):189-204. [QxMD MEDLINE Link].

70. Gao L, Weck MN, Raum E, Stegmaier C, Rothenbacher D, Brenner H. Sibship size, Helicobacter pylori infection and chronic atrophic gastritis: a population-based study among 9444 older adults from Germany. Int J Epidemiol. 2010 Feb. 39(1):129-34. [QxMD MEDLINE Link].

71. Boelaert K, Newby PR, Simmonds MJ, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010 Feb. 123(2):183.e1-9. [QxMD MEDLINE Link].

72. Laberge G, Mailloux CM, Gowan K, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 2005 Aug. 18(4):300-5. [QxMD MEDLINE Link].

73. de Vega Santos T, Zamarron Moreno A, Pascual de Pablo E, Lopez Lopez C. [Pernicious anemia and primary hyperparathyroidism]. Rev Clin Esp. 1995 Mar. 195(3):200-1. [QxMD MEDLINE Link].

74. Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992 Mar. 102(3):760-6. [QxMD MEDLINE Link].

75. Sugiyama T, Nishikawa K, Komatsu Y, et al. Attributable risk of H pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-H pylori ulcers?. Dig Dis Sci. 2001 Feb. 46(2):307-10. [QxMD MEDLINE Link].

76. O'Donohoe JM, Sullivan PB, Scott R, Rogers T, Brueton MJ, Barltrop D. Recurrent abdominal pain and Helicobacter pylori in a community-based sample of London children. Acta Paediatr. 1996 Aug. 85(8):961-4. [QxMD MEDLINE Link].

77. Lindkvist P, Asrat D, Nilsson I, et al. Age at acquisition of Helicobacter pylori infection: comparison of a high and a low prevalence country. Scand J Infect Dis. 1996. 28(2):181-4. [QxMD MEDLINE Link].

78. Gold BD, Colletti RB, Abbott M, et al. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr. 2000 Nov. 31(5):490-7. [QxMD MEDLINE Link].

79. Hall CA, Beebe RT. Early onset of pernicious anaemia in two siblings: genetic and autoimmune aspects. Br J Haematol. 1973 Dec. 25(6):751-6. [QxMD MEDLINE Link].

80. Annibale B, Lahner E, Fave GD. Diagnosis and management of pernicious anemia. Curr Gastroenterol Rep. 2011 Dec. 13(6):518-24. [QxMD MEDLINE Link].

81. Min KU, Metcalfe DD. Eosinophilic gastroenteritis. Immunol Allergy Clin North Am. 1991. 11:799-813.

82. Ndip RN, Malange AE, Akoachere JF, MacKay WG, Titanji VP, Weaver LT. Helicobacter pylori antigens in the faeces of asymptomatic children in the Buea and Limbe health districts of Cameroon: a pilot study. Trop Med Int Health. 2004 Sep. 9(9):1036-40. [QxMD MEDLINE Link].

83. Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014 Apr 10. 345(2):196-202. [QxMD MEDLINE Link].

84. Iacopini F, Consolazio A, Bosco D, et al. Oxidative damage of the gastric mucosa in Helicobacter pylori positive chronic atrophic and nonatrophic gastritis, before and after eradication. Helicobacter. 2003. 8(5):503-12. [QxMD MEDLINE Link].

85. Warren JR. Gastric pathology associated with Helicobacter pylori. Gastroenterol Clin North Am. 2000 Sep. 29(3):705-51. [QxMD MEDLINE Link].

86. Macintyre G, Kooi C, Wong F, Anderson R. On the membrane cytopathology of mouse hepatitis virus infection as probed by a semi-permeable translation-inhibiting drug. Adv Exp Med Biol. 1990. 276:67-72. [QxMD MEDLINE Link].

87. Ito M, Takata S, Tatsugami M, et al. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol. 2009. 44(5):365-71. [QxMD MEDLINE Link].

88. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008 Aug 2. 372(9636):392-7. [QxMD MEDLINE Link].

89. Kamada T, Hata J, Sugiu K, et al. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther. 2005 May 1. 21(9):1121-6. [QxMD MEDLINE Link].

90. Yamamoto K, Kato M, Takahashi M, et al. Clinicopathological analysis of early-stage gastric cancers detected after successful eradication of Helicobacter pylori. Helicobacter. 2011 Jun. 16(3):210-6. [QxMD MEDLINE Link].

91. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med. 1997 Nov 13. 337(20):1441-8. [QxMD MEDLINE Link].

92. Sjoblom SM, Sipponen P, Jarvinen H. Gastroscopic follow up of pernicious anaemia patients. Gut. 1993 Jan. 34(1):28-32. [QxMD MEDLINE Link]. [Full Text].

93. Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013 Jan 10. 368(2):149-60. [QxMD MEDLINE Link].

94. Arvanitakis C. Functional and morphological abnormalities of the small intestinal mucosa in pernicious anemia--a prospective study. Acta Hepatogastroenterol (Stuttg). 1978 Aug. 25(4):313-8. [QxMD MEDLINE Link].

95. Kumar N. Neurologic aspects of cobalamin (B12) deficiency. Handb Clin Neurol. 2014. 120:915-26. [QxMD MEDLINE Link].

96. Ross WA, Ghosh S, Dekovich AA, Liu S, Ayers GD, Cleary KR. Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies. Am J Gastroenterol. 2008 Apr. 103(4):982-9. [QxMD MEDLINE Link].

97. Tahara T, Shibata T, Nakamura M, et al. Gastric mucosal pattern by using magnifying narrow-band imaging endoscopy clearly distinguishes histological and serological severity of chronic gastritis. Gastrointest Endosc. 2009 Aug. 70(2):246-53. [QxMD MEDLINE Link].

98. Anagnostopoulos GK, Ragunath K, Shonde A, Hawkey CJ, Yao K. Diagnosis of autoimmune gastritis by high resolution magnification endoscopy. World J Gastroenterol. 2006 Jul 28. 12(28):4586-7. [QxMD MEDLINE Link].

99. Ford AC, Marwaha A, Lim A, Moayyedi P. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010 Oct. 8(10):830-7, 837.e1-2. [QxMD MEDLINE Link].

100. Oh B, Kim BS, Kim JW, et al. The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial. Helicobacter. 2016 Jun. 21(3):165-74. [QxMD MEDLINE Link].

101. Chakravarty K, Gaur S. Role of probiotics in prophylaxis of Helicobacter pylori infection. Curr Pharm Biotechnol. 2019. 20(2):137-45. [QxMD MEDLINE Link].

102. Rahmani A, Abangah G, Moradkhani A, Hafezi Ahmadi MR, Asadollahi K. Coenzyme Q10 in combination with triple therapy regimens ameliorates oxidative stress and lipid peroxidation in chronic gastritis associated with H. pylori infection. J Clin Pharmacol. 2015 Aug. 55(8):842-7. [QxMD MEDLINE Link].

103. Graham DY, Belson G, Abudayyeh S, Osato MS, Dore MP, El-Zimaity HM. Twice daily (mid-day and evening) quadruple therapy for H pylori infection in the United States. Dig Liver Dis. 2004 Jun. 36(6):384-7. [QxMD MEDLINE Link].

104. Malfertheiner P, Megraud F, O'Morain C, et al for the European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002 Feb. 16(2):167-80. [QxMD MEDLINE Link].

105. Chetty R, Roskell DE. Cytomegalovirus infection in the gastrointestinal tract. J Clin Pathol. 1994 Nov. 47(11):968-72. [QxMD MEDLINE Link]. [Full Text].

106. Griffiths AP, Wyatt J, Jack AS, Dixon MF. Lymphocytic gastritis, gastric adenocarcinoma, and primary gastric lymphoma. J Clin Pathol. 1994 Dec. 47(12):1123-4. [QxMD MEDLINE Link]. [Full Text].

107. Ingle SB, Hinge CR, Dakhure S, Bhosale SS. Isolated gastric Crohn's disease. World J Clin Cases. 2013 May 16. 1(2):71-3. [QxMD MEDLINE Link]. [Full Text].

108. Oberhuber G, Hirsch M, Stolte M. High incidence of upper gastrointestinal tract involvement in Crohn's disease. Virchows Arch. 1998 Jan. 432(1):49-52. [QxMD MEDLINE Link].

109. Shkolnik LE, Shin RD, Brabeck DM, Rothman RD. Symptomatic gastric sarcoidosis in a patient with pulmonary sarcoidosis in remission. BMJ Case Rep. 2012 Jul 13. 2012:[QxMD MEDLINE Link].

110. Weck MN, Gao L, Brenner H. Helicobacter pylori infection and chronic atrophic gastritis: associations according to severity of disease. Epidemiology. 2009 Jul. 20(4):569-74. [QxMD MEDLINE Link].

111. [Guideline] Chey WD, Wong BC, Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007 Aug. 102(8):1808-25. [QxMD MEDLINE Link]. [Full Text].

112. Stent A, Every AL, Chionh YT, Ng GZ, Sutton P. Superoxide dismutase from Helicobacter pylori suppresses the production of pro-inflammatory cytokines during in vivo infection. Helicobacter. 2018 Feb. 23(1). [QxMD MEDLINE Link].

113. Gao X, Zhang Y, Brenner H. Associations of Helicobacter pylori infection and chronic atrophic gastritis with accelerated epigenetic ageing in older adults. Br J Cancer. 2017 Oct 10. 117(8):1211-4. [QxMD MEDLINE Link].

114. Estevam RB, Wood da Silva NMJ, Wood da Silva, et al. Modulation of Galectin-3 and Galectin 9 in gastric mucosa of patients with chronic gastritis and positive Helicobacter pylori infection. Pathol Res Pract. 2017 Oct. 213(10):1276-81. [QxMD MEDLINE Link].

Akiva J Marcus, MD, PhD Attending Gastroenterologist, West Palm Hospital

Akiva J Marcus, MD, PhD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Medical Association, American Society for Gastrointestinal Endoscopy, New York Society for Gastrointestinal Endoscopy, International Society for Stem Cell Research

Disclosure: Nothing to disclose.

David Greenwald, MD Professor of Clinical Medicine, Fellowship Program Director, Department of Medicine, Division of Gastroenterology, Montefiore Medical Center, Albert Einstein College of Medicine

David Greenwald, MD is a member of the following medical societies: Alpha Omega Alpha, New York Society for Gastrointestinal Endoscopy, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

BS Anand, MD Professor, Department of Internal Medicine, Division of Gastroenterology, Baylor College of Medicine

BS Anand, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Simmy Bank, MD Chair, Professor, Department of Internal Medicine, Division of Gastroenterology, Long Island Jewish Hospital, Albert Einstein College of Medicine

Disclosure: Nothing to disclose.

Franco Bazzoli, MD Professor, Department of Internal Medicine and Gastroenterology, University of Bologna, Italy

Franco Bazzoli, MD is a member of the following medical societies: American Gastroenterological Association

Disclosure: Nothing to disclose.

Maria P Dore, MD Associate Professor, Department of Medicine, Institute of Internal Medicine, University of Sassari, Italy

Maria P Dore, MD is a member of the following medical societies: American Gastroenterological Association

Disclosure: Nothing to disclose.

Sandeep Mukherjee, MB, BCh, MPH, FRCPC Associate Professor, Department of Internal Medicine, Section of Gastroenterology and Hepatology, University of Nebraska Medical Center; Consulting Staff, Section of Gastroenterology and Hepatology, Veteran Affairs Medical Center

Sandeep Mukherjee, MB, BCh, MPH, FRCPC is a member of the following medical societies: Royal College of Physicians and Surgeons of Canada

Disclosure: Merck Honoraria Speaking and teaching; Ikaria Pharmaceuticals Honoraria Board membership

Tushar Patel, MB, ChB Professor of Medicine, Ohio State University Medical Center

Tushar Patel, MB, ChB is a member of the following medical societies: American Association for the Study of Liver Diseases and American Gastroenterological Association

Disclosure: Nothing to disclose.

Antonia R Sepulveda, MD, PhD Professor of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine; Director of Surgical Pathology, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania

Antonia R Sepulveda, MD, PhD is a member of the following medical societies: American Association for Cancer Research, American Gastroenterological Association, American Society for Investigative Pathology, College of American Pathologists, and United States and Canadian Academy of Pathology

Disclosure: Genentech Honoraria Consulting; Leica Honoraria Consulting

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Reference Salary Employment

• Print this section
• Print the entire contents of
• Print the entire contents of article